Abnormal excitability and episodic low-frequency oscillations in the cerebral cortex of the tottering mouse.
Samuel W CramerLaurentiu S PopaRussell E CarterGang ChenTimothy J EbnerPublished in: The Journal of neuroscience : the official journal of the Society for Neuroscience (2015)
The Ca(2+) channelopathies caused by mutations of the CACNA1A gene that encodes the pore-forming subunit of the human Cav2.1 (P/Q-type) voltage-gated Ca(2+) channel include episodic ataxia type 2 (EA2). Although, in EA2 the emphasis has been on cerebellar dysfunction, patients also exhibit episodic, nonmotoric abnormalities involving the cerebral cortex. This study demonstrates episodic, low-frequency oscillations (LFOs) throughout the cerebral cortex of tottering (tg/tg) mice, a widely used model of EA2. Ranging between 0.035 and 0.11 Hz, the LFOs in tg/tg mice can spontaneously develop very high power, referred to as a high-power state. The LFOs in tg/tg mice are mediated in part by neuronal activity as tetrodotoxin decreases the oscillations and cortical neuron discharge contain the same low frequencies. The high-power state involves compensatory mechanisms because acutely decreasing P/Q-type Ca(2+) channel function in either wild-type (WT) or tg/tg mice does not induce the high-power state. In contrast, blocking l-type Ca(2+) channels, known to be upregulated in tg/tg mice, reduces the high-power state. Intriguingly, basal excitatory glutamatergic neurotransmission constrains the high-power state because blocking ionotropic or metabotropic glutamate receptors results in high-power LFOs in tg/tg but not WT mice. The high-power LFOs are decreased markedly by acetazolamide and 4-aminopyridine, the primary treatments for EA2, suggesting disease relevance. Together, these results demonstrate that the high-power LFOs in the tg/tg cerebral cortex represent a highly abnormal excitability state that may underlie noncerebellar symptoms that characterize CACNA1A mutations.
Keyphrases
- wild type
- high fat diet induced
- subarachnoid hemorrhage
- working memory
- computed tomography
- adipose tissue
- endothelial cells
- functional connectivity
- early onset
- magnetic resonance
- transcription factor
- newly diagnosed
- chronic kidney disease
- protein kinase
- end stage renal disease
- genome wide
- brain injury
- cerebral ischemia
- insulin resistance
- ejection fraction
- peritoneal dialysis
- sleep quality
- contrast enhanced
- genome wide identification